Delayed
Hong Kong S.E.
09:38:57 2024-04-28 pm EDT
|
5-day change
|
1st Jan Change
|
0.37
HKD
|
0.00%
|
|
0.00%
|
-15.91%
|
Fiscal Period: March |
2018
|
2019
|
2020
|
2021
|
2022
|
2023
|
---|
Capitalization
1 |
1,083
|
814.5
|
289.7
|
356.9
|
589.8
|
404.4
|
Enterprise Value (EV)
1 |
604.3
|
588.1
|
89.5
|
-74.3
|
622.8
|
446.4
|
P/E ratio
|
8.66
x
|
79.5
x
|
26.4
x
|
4.39
x
|
7
x
|
18
x
|
Yield
|
5.81%
|
1.69%
|
3.8%
|
14%
|
6.79%
|
4.38%
|
Capitalization / Revenue
|
0.28
x
|
0.24
x
|
0.09
x
|
0.1
x
|
0.14
x
|
0.1
x
|
EV / Revenue
|
0.16
x
|
0.17
x
|
0.03
x
|
-0.02
x
|
0.15
x
|
0.11
x
|
EV / EBITDA
|
3
x
|
7.46
x
|
1.17
x
|
-0.56
x
|
3.84
x
|
3.51
x
|
EV / FCF
|
12.4
x
|
-4.64
x
|
0.38
x
|
-0.32
x
|
-3.94
x
|
2.23
x
|
FCF Yield
|
8.08%
|
-21.6%
|
267%
|
-317%
|
-25.4%
|
44.9%
|
Price to Book
|
0.8
x
|
0.63
x
|
0.23
x
|
0.26
x
|
0.43
x
|
0.31
x
|
Nbr of stocks (in thousands)
|
839,740
|
839,740
|
839,740
|
839,740
|
842,540
|
842,540
|
Reference price
2 |
1.290
|
0.9700
|
0.3450
|
0.4250
|
0.7000
|
0.4800
|
Announcement Date
|
7/18/18
|
7/11/19
|
7/30/20
|
7/15/21
|
7/19/22
|
7/24/23
|
Fiscal Period: Marzo |
2018
|
2019
|
2020
|
2021
|
2022
|
2023
|
---|
Net sales
1 |
3,868
|
3,420
|
3,262
|
3,597
|
4,185
|
4,205
|
EBITDA
1 |
201.8
|
78.82
|
76.22
|
132.4
|
162.2
|
127
|
EBIT
1 |
150.9
|
26.9
|
21.68
|
75.26
|
97.72
|
55.9
|
Operating Margin
|
3.9%
|
0.79%
|
0.66%
|
2.09%
|
2.34%
|
1.33%
|
Earnings before Tax (EBT)
1 |
158.8
|
13.92
|
14.87
|
102.5
|
102.9
|
31.39
|
Net income
1 |
126.4
|
10.29
|
10.99
|
81.39
|
84.23
|
22.5
|
Net margin
|
3.27%
|
0.3%
|
0.34%
|
2.26%
|
2.01%
|
0.54%
|
EPS
2 |
0.1490
|
0.0122
|
0.0131
|
0.0969
|
0.1000
|
0.0267
|
Free Cash Flow
1 |
48.83
|
-126.8
|
238.7
|
235.3
|
-158.2
|
200.2
|
FCF margin
|
1.26%
|
-3.71%
|
7.31%
|
6.54%
|
-3.78%
|
4.76%
|
FCF Conversion (EBITDA)
|
24.2%
|
-
|
313.12%
|
177.69%
|
-
|
157.6%
|
FCF Conversion (Net income)
|
38.63%
|
-
|
2,170.93%
|
289.1%
|
-
|
889.72%
|
Dividend per Share
2 |
0.0750
|
0.0164
|
0.0131
|
0.0595
|
0.0475
|
0.0210
|
Announcement Date
|
7/18/18
|
7/11/19
|
7/30/20
|
7/15/21
|
7/19/22
|
7/24/23
|
Fiscal Period: March |
2018
|
2019
|
2020
|
2021
|
2022
|
2023
|
---|
Net Debt
1 |
-
|
-
|
-
|
-
|
33
|
42
|
Net Cash position
1 |
479
|
226
|
200
|
431
|
-
|
-
|
Leverage (Debt/EBITDA)
|
-
|
-
|
-
|
-
|
0.2037
x
|
0.3303
x
|
Free Cash Flow
1 |
48.8
|
-127
|
239
|
235
|
-158
|
200
|
ROE (net income / shareholders' equity)
|
9.71%
|
0.78%
|
0.86%
|
6.13%
|
6.01%
|
1.74%
|
ROA (Net income/ Total Assets)
|
4.02%
|
0.75%
|
0.6%
|
1.95%
|
2.31%
|
1.22%
|
Assets
1 |
3,148
|
1,381
|
1,844
|
4,167
|
3,646
|
1,849
|
Book Value Per Share
2 |
1.610
|
1.530
|
1.500
|
1.670
|
1.650
|
1.560
|
Cash Flow per Share
2 |
0.8700
|
0.5200
|
0.5100
|
0.7000
|
0.4100
|
0.3700
|
Capex
1 |
96.3
|
72.5
|
85.2
|
104
|
101
|
92.3
|
Capex / Sales
|
2.49%
|
2.12%
|
2.61%
|
2.88%
|
2.41%
|
2.19%
|
Announcement Date
|
7/18/18
|
7/11/19
|
7/30/20
|
7/15/21
|
7/19/22
|
7/24/23
|
|
1st Jan change
|
Capi.
|
---|
| -15.91% | 39.82M | | +6.56% | 32.91B | | +17.38% | 8.1B | | -2.71% | 6.98B | | +20.18% | 5.45B | | -3.97% | 4.13B | | +34.04% | 3.95B | | +17.24% | 3.8B | | +5.47% | 3.4B | | -9.99% | 2.72B |
Testing & Measuring Equipment
|